Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY DEFICIT

v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Total Mezzanine Equity [Member]
Convertible Preferred Stock Series B Shares [Member]
Convertible Preferred Stock Series B 1 Shares [Member]
Convertible Preferred Stock Series C Shares [Member]
Convertible Preferred Stock Series C 1 Shares [Member]
Convertible Preferred Stock Series D Shares [Member]
Convertible Preferred Stock Series D 1 Shares [Member]
Convertible Preferred Stock Series D 2 Shares [Member]
Convertible Preferred Stock Series E Shares [Member]
Convertible Preferred Stock Series E 1 Shares [Member]
Convertible Preferred Stock Series F Shares [Member]
Convertible Preferred Stock Series F 1 Shares [Member]
Convertible Preferred Stock Series G Shares [Member]
Convertible Preferred Stock Series H Shares [Member]
Convertible Preferred Stock Total Shares [Member]
Legacy Airspan Common Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Common Shares [Member]
Common B Shares [Member]
Balance at December 31, 2019, effect of Business Combination (Note 3) at Dec. 31, 2018 $ 309,923                             $ 308,788 $ (669,682) $ (360,894)    
Balance at beginning, shares at Dec. 31, 2018   72,123 416,667 1,450,993 325,203 615,231 393,511 352,076 46,325 3,672,129         202,582 466,952
Retrospective application of the recapitalization due to the Business Combination (Note 3) (309,923)                             $ 6 363,475 363,481    
Retrospective application of the recapitalization due to the Business Combination, shares   (72,123)   (416,667)   (1,450,993) (325,203)   (615,231) (393,511) (352,076) (46,325)     (3,672,129)   59,710,047       (202,582) (466,952)
Ending balance, value at Dec. 31, 2019 363,481                             311,431 (695,325) (383,894)    
Balance at ending, shares at Dec. 31, 2019   72,123 416,667 1,080,993 325,203 370,000 615,231 393,511 352,076 46,325 740,987 168,288 4,581,404         202,582 466,952
Balance at December 31, 2019, effect of Business Combination (Note 3) at Dec. 31, 2019                             $ 6 672,263 (669,682) 2,587    
Balance at beginning, shares at Dec. 31, 2019     59,710,047      
Net loss                               (13,015) (13,015)    
Ending balance, value at Mar. 31, 2020                             $ 6 672,755 (682,697) (9,936)    
Balance at ending, shares at Mar. 31, 2020     59,710,047      
Share-based compensation expense                               492 492    
Beginning balance, value at Dec. 31, 2019 363,481                             311,431 (695,325) (383,894)    
Balance at ending, shares at Dec. 31, 2019   72,123 416,667 1,080,993 325,203 370,000 615,231 393,511 352,076 46,325 740,987 168,288 4,581,404         202,582 466,952
Balance at December 31, 2019, effect of Business Combination (Note 3) at Dec. 31, 2019                             $ 6 672,263 (669,682) 2,587    
Balance at beginning, shares at Dec. 31, 2019     59,710,047      
Net loss                                       (33,989)    
Ending balance, value at Sep. 30, 2020                             $ 6 673,745 (703,671) (29,920)    
Balance at ending, shares at Sep. 30, 2020       59,710,047        
Beginning balance, value at Dec. 31, 2019 363,481                             311,431 (695,325) (383,894)    
Balance at ending, shares at Dec. 31, 2019   72,123 416,667 1,080,993 325,203 370,000 615,231 393,511 352,076 46,325 740,987 168,288 4,581,404         202,582 466,952
Balance at December 31, 2019, effect of Business Combination (Note 3) at Dec. 31, 2019                             $ 6 672,263 (669,682) 2,587    
Balance at beginning, shares at Dec. 31, 2019     59,710,047      
Retrospective application of the recapitalization due to the Business Combination (Note 3) (363,481)                             $ 6 363,475 363,481    
Retrospective application of the recapitalization due to the Business Combination, shares   (72,123) (416,667) (1,080,993) (325,203) (370,000) (615,231) (393,511) (352,076) (46,325) (740,987) (168,288) (4,581,404)   59,710,047       (202,582) (466,952)
Ending balance, value at Dec. 31, 2020                             $ 6 674,906 (695,325) (20,413)    
Balance at ending, shares at Dec. 31, 2020            
Beginning balance, value at Mar. 31, 2020                             $ 6 672,755 (682,697) (9,936)    
Balance at ending, shares at Mar. 31, 2020     59,710,047      
Net loss                               (11,053) (11,053)    
Ending balance, value at Jun. 30, 2020                             $ 6 673,250 (693,750) (20,494)    
Balance at ending, shares at Jun. 30, 2020     59,710,047      
Share-based compensation expense                               495 495    
Net loss                               (9,921) (9,921)    
Ending balance, value at Sep. 30, 2020                             $ 6 673,745 (703,671) (29,920)    
Balance at ending, shares at Sep. 30, 2020       59,710,047        
Share-based compensation expense                               495 495    
Beginning balance, value at Dec. 31, 2020                             6 674,906 (695,325) (20,413)    
Balance at ending, shares at Dec. 31, 2020            
Net loss                               (13,549) (13,549)    
Ending balance, value at Mar. 31, 2021                             $ 6 676,220 (708,874) (32,648)    
Balance at ending, shares at Mar. 31, 2021     59,710,047      
Share-based compensation expense                               661 661    
Issuance of Series H preferred stock, net of issuance costs                               653 653    
Beginning balance, value at Dec. 31, 2020                             6 674,906 (695,325) (20,413)    
Balance at ending, shares at Dec. 31, 2020            
Net loss                                       (50,920)    
Ending balance, value at Sep. 30, 2021                             $ 7 740,169 (746,245) (6,069)    
Balance at ending, shares at Sep. 30, 2021     72,024,437      
Beginning balance, value at Mar. 31, 2021                             $ 6 676,220 (708,874) (32,648)    
Balance at ending, shares at Mar. 31, 2021     59,710,047      
Net loss                               (10,418) (10,418)    
Ending balance, value at Jun. 30, 2021                             $ 6 677,117 (719,292) (42,169)    
Balance at ending, shares at Jun. 30, 2021     59,724,324      
Exercise of common stock options                               69 $ 69    
Exercise of common stock options, shares                                       14,277    
Share-based compensation expense                               828 $ 828    
Net loss                               (26,953) (26,953)    
Ending balance, value at Sep. 30, 2021                             $ 7 740,169 (746,245) (6,069)    
Balance at ending, shares at Sep. 30, 2021     72,024,437      
Exercise of common stock options                               10 $ 10    
Exercise of common stock options, shares                                       2,162    
Extinguishment of pre-combination warrant liability in connection with the Reverse Recapitalization                               10,284 $ 10,284    
Business Combination and PIPE financing, net of redemptions and equity issuance costs of $26.2 million                               1 52,097 $ 52,098    
Business Combination and PIPE financing, net of redemptions and equity issuance costs of $26.2 million, shares                                       12,297,951    
Share-based compensation expense                               $ 661 $ 661